Glofitamab Regimen Improves Survival in DLBCL

Published Date: 24 Jun 2024

Granted accelerated approval last year, bispecific antibody passes its confirmatory test

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Obesity-associated cancers tripled nationwide over past two decades

2.

Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.

3.

Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.

4.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

5.

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot